The Technical AnalystExchange: PNK Industry: Drug Manufacturers
Nexien BioPharma, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
2.45% $0.0167
America/New_York / 3 mai 2024 @ 14:22
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1.127 mill |
| EPS: | -0.0100 |
| P/E: | -1.670 |
| Earnings Date: | May 17, 2024 |
| SharesOutstanding: | 67.47 mill |
| Avg Daily Volume: | 0.0100 mill |
| RATING 2024-05-03 |
|---|
| C |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.670 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -1.670 | industry: PE -6.21 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-0.0038 (-122.70%) $-0.0205 |
| Date: 2024-05-04 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0107 - 0.0227 ( +/- 35.93%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-10-31 | Greenberg Richard S | Buy | 250 000 | Common Stock |
| 2023-10-31 | Wasoff Evan L | Buy | 250 000 | Common stock |
| 2023-07-25 | Goldfarb Robert I | Buy | 250 000 | Common Stock |
| 2023-04-01 | Goldfarb Robert I | Buy | 250 000 | Common Stock |
| 2020-08-19 | Goldfarb Robert I | Buy | 1 000 000 | Options to purchase common stock (right to buy) |
| INSIDER POWER |
|---|
| 100.00 |
| Last 97 transactions |
| Buy: 75 102 826 | Sell: 17 443 467 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.0167 (2.45% ) |
| Volume | 0.0536 mill |
| Avg. Vol. | 0.0100 mill |
| % of Avg. Vol | 538.25 % |
| Signal 1: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NXEN
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NXEN
Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.